The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Exploring the future of peptides. BPC 157 is a research peptide currently being studied for its potential role in joint and tissue support. It's important to understand: this compound is not FDA approved for The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 10MG Oneday Compounds Research Peptides for Sale Phoenix Pharmaceuticals, Inc.